Highly Active Antiretroviral Therapy for Patients with AIDS Dementia Complex: Effect on MR Imaging Findings and Clinical Course

References

1. ↵
   Budka H, Constanzi G, Cristina S, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV): a histological, immunohistochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987;75:185-198

   CrossRefPubMedWeb of Science
2. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol 1989;77:225-236

   CrossRefPubMed
3. ↵
   Post MJD, Tate LG, Quencer RM, et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am J Roentgenol 1988;151:373-380

   PubMedWeb of Science
4. ↵
   Broderick DF, Wippold FJ II, Clifford DB, Kido D, Wilson BS. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol 1993;161:177-181

   CrossRefPubMed
5. ↵
   Olsen WL, Longo FM, Mills CM, Norman D. White matter disease in AIDS: findings at MR imaging. Radiology 1988;169:445-448

   CrossRefPubMedWeb of Science
6. Hawkins CP, McLaughlin JE, Kendall BE, McDonald WI. Pathological findings correlated with MRI in HIV infection. Neuroradiology 1993;35:264-268

   CrossRefPubMedWeb of Science
7. Grassi MP, Clerici F, Boldorini R, et al. HIV encephalitis and HIV leukoencephalopathy are associated with distinct clinical and radiological subtypes of the AIDS dementia complex. AIDS 1997;11:690-691

   PubMed
8. ↵
   Carpenter CJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA 1996;276:146-154

   CrossRefPubMedWeb of Science
9. Barry M, Gibbons S, Back D, Mulcahy F. Protease inhibitors in patients with HIV disease. Clin Pharmacokinet 1997;32:194-209

   CrossRefPubMedWeb of Science
10. Noble S, Faulds D, Saquinavir A review of its pharmacology and clinical potential in the management of HIV infection. Drugs 1996;52:93-112

    CrossRefPubMedWeb of Science
11. Deeks SG, Smith M, Holodniy M, Kahn J. HIV-1 protease inhibitors: a review for clinicians. JAMA 1997;277:145-153

    CrossRefPubMedWeb of Science
12. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995;333:1534-1539

    CrossRefPubMedWeb of Science
13. Mileno MD, Tashima K, Farrar D, Elliot BD, Rich JD, Flanigan TP. Resolution of AIDS-related opportunistic infections with addition of protease inhibitor treatment. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, 1997
14. ↵
    Filippi CG, Sze G, Farber SJ, Shahmanesh M, Selwyn PA. Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy. Radiology 1998;206:491-498

    PubMedWeb of Science
15. ↵
    Navia BA, Jordan BD, Price RW. The AIDS dementia complex, I: clinical features. Ann Neurol 1986;19:517-524

    CrossRefPubMedWeb of Science
16. ↵
    Albert ML, Feldman RG, Willis AL. The “subcortical dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974;37:121-130

    Abstract/FREE Full Text
17. ↵
    Poutiainen E, Haltia M, Elovaara I, Lähdevirta J, Iivanainen M. Dementia associated with human immunodeficiency virus: subcortical or cortical? Acta Psychiatry Scand 1991;83:297-301

    CrossRefPubMed
18. Arendt G, Hefter H, Neuen-Jacob E, et al. Electrophysiological motor testing, MRI findings and clinical course in AIDS patients with dementia. J Neurol 1993;240:439-445

    CrossRefPubMedWeb of Science
19. ↵
    Glass JD, Wesselingh SL, Selnes OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-2237

    Abstract/FREE Full Text
20. Bencherif B, Rottenberg DA. Neuroimaging of the AIDS dementia complex. AIDS 1998;12:233-244

    PubMed
21. Chrysikopoulos HS, Press GA, Grafe MR, Hesselink JR, Wiley CA. Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology 1990;175:185-191

    CrossRefPubMedWeb of Science
22. Raininko R, Elovaara I, Virta A, Valanne L, Haltia M, Valle SL. Radiological study of the brain at various stages of human immunodeficiency virus infection: early development of brain atrophy. Neuroradiology 1992;34:190-196

    CrossRefPubMedWeb of Science
23. Grafe MR, Press GA, Berthoty DP, Hesselink JR, Wiley CA. Abnormalities of the brain in AIDS patients: correlation of post mortem MR findings with neuropathology. AJNR Am J Neuroradiol 1990;11:905-911

    Abstract/FREE Full Text
24. ↵
    Brouwers P, Hendricks M, Lietzau JA, et al. Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: a comparison of simultaneous and altering regimens. AIDS 1997;11:59-66

    CrossRefPubMedWeb of Science
25. Vago L, Castagna A, Lazzarin A, Cinque P, Trabattoni G, Constanzi G. Zidovudine and frequency of HIV-induced diffuse leukoencephalopathy. Lancet 1991;337:1488

    PubMedWeb of Science
26. Sidtis J, Gatsonis C, Price R, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann Neurol 1993;33:343-349

    CrossRefPubMedWeb of Science
27. Tozzi V, Narciso P, Galgani S, et al. Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex. AIDS 1993;7:683-692

    PubMedWeb of Science
28. ↵
    Post MJD, Levin BE, Berger JR, Duncan R, Quencer RM, Calabro G. Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects. AJNR Am J Neuroradiol 1992;13:359-370

    Abstract/FREE Full Text
29. ↵
    Bartlett J. 1998; Medical Management of HIV Infection.. Baltimore: Johns Hopkins University Press; 1998
30. ↵
    Sactor NC. Advances in the treatment of HIV dementia. AIDS Reader 1999;9:57-60

    PubMed
31. ↵
    Gendelman HE, Zheng J, Coulter CL, et al. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus–associated dementia. J Infect Dis 1998;178:1000-1007

    CrossRefPubMedWeb of Science
32. Sactor N, Skolasky R, Esposito D, et al. Combination therapy including protease inhibitors improves psychomotor speed performance in HIV infection. Neurology 1998;50:A248-A249
33. Sactor N, Skolasky R, Lyles R, et al. Highly active antiretroviral therapy (HAART) improves cognitive impairment in HIV+ homosexual men. J Neurovirol 1998;4:365
34. ↵
    Murray JS, Elashoff MR, Iacono-Connors LC, Cvetkovich TA, Struble KA. The use of HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS 1999;13:797-804

    CrossRefPubMedWeb of Science